Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for conscious sedation during modified awake flexible fiberoptic intubation
ChiCTR-TRC-13003151Phase 4Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Mar 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and dexmedetomidine in difficult airway (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Time to achieve required depth of sedation, Intubation time and 3 more. Started Mar 2013; status: completed.
02
Drugs
remifentanildexmedetomidine
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR-TRC-13003151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003151.